Phibro Animal Health

Phibro Animal Health Corporation is a leading global company focused on animal health and mineral nutrition, primarily serving the food production sector. The company develops, manufactures, and markets a wide range of products for various food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its diverse product portfolio encompasses animal health solutions such as antibacterials, anticoccidials, nutritional specialty products, and vaccines, along with mineral nutrition offerings. Phibro operates through three main segments: Animal Health, Mineral Nutrition, and Performance Products, with the majority of its revenue generated from the Animal Health segment. By concentrating exclusively on enhancing animal health and nutrition, Phibro aims to address the increasing global demand for animal protein.

Glenn David

CFO

Richard Johnson

interim CFO

7 past transactions

Osprey Biotechnics

Acquisition in 2019
Osprey Biotechnics is a company based in Sarasota, Florida, focused on the development and manufacture of microbial products for various applications. The company specializes in contract fermentation and manufacturing, producing animal probiotics, agricultural biopesticides, and consumer microbial products. These offerings are available under Osprey's own brand as well as through private labels, catering to environmental, industrial, and agricultural clients.

KoVax

Acquisition in 2018
KoVax Ltd., founded in 2003, specializes in the development, manufacture, and marketing of vaccines aimed at eradicating fish diseases. The company is recognized as the sole producer of an effective and safe vaccine against CyHV3 (KHV) disease, a significant threat to aquatic health. By focusing on aquaculture vaccines, KoVax plays a crucial role in promoting the health and sustainability of fish populations, thereby supporting the broader aquaculture industry.

Biotay

Acquisition in 2017
Biotay SA, established in 1985 and headquartered in Grand Bourg, Argentina, specializes in the manufacture and marketing of animal health and nutritional products. The company focuses on enhancing productivity, improving nutritional and health quality in livestock, and promoting animal welfare. Biotay engages with the animal food production chain, providing technological solutions to livestock producers and professionals throughout Argentina. As of September 2017, Biotay operates as a subsidiary of Phibro Animal Health Corporation.

MVP Laboratories

Acquisition in 2016
MVP Laboratories, Inc. is a manufacturer of veterinary medicines, specializing in vaccines for livestock animals. Founded in 1981 and headquartered in Omaha, Nebraska, the company produces conventional and autogenous vaccines aimed at preventing diseases in swine and bovine populations, as well as veterinary vaccine adjuvants. In addition to vaccines, MVP Laboratories develops dietary supplements for geriatric dogs and cats to address specific health needs and common ailments. The company also offers a range of services, including diagnostics, toll manufacturing, private labeling, consultation, and virus production. MVP Laboratories serves practicing veterinarians and their clients both domestically and internationally.

OAE Holdings Pty

Acquisition in 2014
OAE Holdings Pty Ltd develops, produces, and markets animal health products primarily to the poultry sector.

Aqua-Vet

Acquisition in 2014
Aqua-Vet Ltd. operates as a technical consulting and contract research organization focused on the global aquaculture market.

ABIC Biological Laboratories

Acquisition in 2009
ABIC Biological Laboratories Ltd. develops, produces, and markets animal health products primarily to the poultry sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.